These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 14696087

  • 1. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
    Osada S, Saji S, Kuno T.
    J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
    [Abstract] [Full Text] [Related]

  • 2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 3. Apoptosis, PCNA and p53 in hepatocellular carcinoma.
    Paiva C, Oshima CT, Lanzoni VP, Forones NM.
    Hepatogastroenterology; 2002 May; 49(46):1058-61. PubMed ID: 12143201
    [Abstract] [Full Text] [Related]

  • 4. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 5. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I.
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A, Yano H, Yamaguchi H, Tanaka K, Shibasaki S, Sumida Y, Sawai T, Shindou H, Nakagoe T.
    J Gastroenterol; 2004 Dec; 39(2):148-54. PubMed ID: 15069621
    [Abstract] [Full Text] [Related]

  • 7. [DNA ploidy pattern, p53 immunohistochemical overexpression and PCNA labeling index in "single nodular" human hepatocellular carcinomas from the viewpoint of biological malignant potential].
    Saiki I, Une Y, Uchino J.
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():103-9. PubMed ID: 7611770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M, Hirooka Y, Kaibara N.
    Cancer; 2002 Nov 01; 95(9):1938-45. PubMed ID: 12404288
    [Abstract] [Full Text] [Related]

  • 10. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, Miyake H, Isikawa M, Izumi K, Sano N.
    Clin Cancer Res; 1998 Jun 01; 4(6):1475-82. PubMed ID: 9626465
    [Abstract] [Full Text] [Related]

  • 11. [Correlation between prognosis and cell proliferation, apoptosis in squamous cell carcinoma of tongue].
    Yang YP, Qing HY, Cao Y.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan 01; 38(1):31-4. PubMed ID: 12760773
    [Abstract] [Full Text] [Related]

  • 12. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D, Zheng H, Shen M, Cheng R, Yan Y.
    Hunan Yi Ke Da Xue Xue Bao; 1999 Jan 01; 24(4):325-8. PubMed ID: 12080637
    [Abstract] [Full Text] [Related]

  • 13. Expression of p57(KIP2) in hepatocellular carcinoma: relationship between tumor differentiation and patient survival.
    Nakai S, Masaki T, Shiratori Y, Ohgi T, Morishita A, Kurokohchi K, Watanabe S, Kuriyama S.
    Int J Oncol; 2002 Apr 01; 20(4):769-75. PubMed ID: 11894123
    [Abstract] [Full Text] [Related]

  • 14. Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.
    J Surg Oncol; 2007 Mar 01; 95(3):241-9. PubMed ID: 17323338
    [Abstract] [Full Text] [Related]

  • 15. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma.
    Mitsuhashi N, Kobayashi S, Doki T, Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Nozawa S, Furukawa K, Takeuchi D, Suda K, Miura S, Miyazaki M.
    J Gastroenterol Hepatol; 2008 Jul 01; 23(7 Pt 2):e189-97. PubMed ID: 18466288
    [Abstract] [Full Text] [Related]

  • 16. Hepatic fibrosis influences the growth of hepatocellular carcinoma.
    Osada S, Kanematsu M, Imai H, Goshima S, Sugiyama Y.
    Hepatogastroenterology; 2008 Jul 01; 55(81):184-7. PubMed ID: 18507103
    [Abstract] [Full Text] [Related]

  • 17. Proliferative activity and apoptosis in thymic epithelial neoplasms.
    Hiroshima K, Iyoda A, Toyozaki T, Supriatna Y, Shibuya K, Shimamura F, Haga Y, Yoshida S, Fujisawa T, Ohwada H.
    Mod Pathol; 2002 Dec 01; 15(12):1326-32. PubMed ID: 12481014
    [Abstract] [Full Text] [Related]

  • 18. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
    Shabnam MS, Srinivasan R, Wali A, Majumdar S, Joshi K, Behera D.
    Lung Cancer; 2004 Aug 01; 45(2):181-8. PubMed ID: 15246189
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T, Mukai K, Yamaguchi N, Ishihara K, Kaneko A, Takasaki Y, Shimosato Y.
    Mod Pathol; 1994 Jan 01; 7(1):37-43. PubMed ID: 7909154
    [Abstract] [Full Text] [Related]

  • 20. Proliferating cell nuclear antigen and grade of malignancy in small hepatocellular carcinoma--evaluation in US-guided specimens.
    Hino N, Higashi T, Nouso K, Nakatsukasa H, Urabe Y, Kinugasa N, Yoshida K, Ashida K, Ohguchi S, Tsuji T.
    Hepatogastroenterology; 1997 Jan 01; 44(13):245-50. PubMed ID: 9058153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.